Oxford Nanopore Technologies plc

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40000454

Informations générales

Localisation

United Kingdom

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

20/02/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2045

Statut

Targets set

Classification

1.5°C

Année cible

2045

Progression vers l'objectif37%
2015 (année de référence)2045
Description complète des objectifs

Overall Net-Zero Target: Oxford Nanopore Technologies plc commits to reach net-zero greenhouse gas emissions across the value chain by 2045. Near-Term Targets: Oxford Nanopore Technologies plc commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2023 base year. Oxford Nanopore Technologies plc also commits to reduce scope 3 GHG emissions 52% per GBP value added withtin the same timeframe. Long-Term Targets: Oxford Nanopore Technologies plc commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by 2045 from a 2023 base year.

Net-Zero

Statut

Targets set

Année cible

2045

Progression37%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

GB00BP6S8Z30

LEI

213800IRWQ2Q6M2CDW55

Source : Science Based Targets initiative | Données publiques